Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-207-5 | CAS number: 1950616-36-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to the O.E.C.D. test guideline 429 LLNA with GLP compliance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction products of 2-methylimidazole and 2,2'-[(1- methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
- EC Number:
- 701-436-0
- Molecular formula:
- (C15H16O2.C4H6N2.C3H5ClO)x
- IUPAC Name:
- Reaction products of 2-methylimidazole and 2,2'-[(1- methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
- Test material form:
- other: Liquid at room temperature.
- Details on test material:
- As per IUCLID5 Sections 1.1. 1.2. 1.3. and 4.1.
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- The experimental animals were purchased from Harlan Sprague-Dawley; Indianapolis, IN and weighted 20.1 - 24.5 gm at Experimental initiation. The mice were housed in polycarbonate boxes with bedding 1-5 per cage. The animal room was operated at 19-22°C with a relative humidity range of 49-91% and a 10-12 air changes/hour with 12-hour light/dark cycle. PMI Feeds Inc.TM Formulab #5 008 was available ad libitum and
Municipal water supply analyzed by TCEQ Water Utilities Division was available ad libitum from automatic water system.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100 % v/v in 80% acetone:20% olive oil
- No. of animals per dose:
- 5
- Details on study design:
- Five female mice were selected for each of three Test groups. On Days 1, 2 and 3, each Test animal in its group received an open application of 25 uL of an appropriate dilution (25% or 50%) of the test substance, or 100% test substance undiluted, to the dorsum of both ears. The Vehicle Control group (5 females) was treated in the same way as test animals, but with vehicle alone (acetone:olive oil) instead of test substance. The Positive Control group (5 females) was treated with 80% alpha-hexylcinnamaldehyde in acetone:olive oil. All Test and Control animals were given a two-day rest period on Days 4 and 5.
On Day 6 of the study, all Test and Control animals were injected in the tail vein with 250 1uL of 0.01 M phosphate-buffered saline (PBS) pH 7.4 at 25°C per manufacturer, containing 20 uCi of {methyl-3H1 Thymidine. Five hours after the injection, the animals were sacrificed with an overdose of CO2, the draining auricular lymph nodes were excised and pairs from each individual animal were processed.
A single cell suspension was prepared by gentle mechanical disintegration through 200 mesh stainless steel gauze. The cells were washed twice with an excess of PBS and precipitated with 5% trich1oroacetic acid at 4°C for 18 hours. The pellets were resuspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. Incorporation of tritiated thymidine was measured by liquid scintillation counting as disintegrations per minute (DPM) from the paired lymph nodes of each animal, and mean DPM/animal was calculated for each group.
Individual body weights were recorded on Day 1 prior to dosing, and Day 6, prior to injection. All Test and Control animals were observed daily for clinical signs of toxicity and any signs of excessive irritation at the test site. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not conducted.
Results and discussion
- Positive control results:
- The mean Stimulation Index (SI) or Test/Vehicle Control DPM Ratio was 6.8.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Test Substance 25% 6.8 Test Substance 50% 3.2 Test Substance 100% 10.3 Positive control 6.8
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Group Mean DPM Vehicle control 33494 Test Substance 25% 23786 Test Substance 50% 11128 Test Substance 100% 35829 Positive Control 23807
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: Peer reviewed publication
- Conclusions:
- The test substance is a skin sensitizer under the conditions of the study inducing a SI of > 3-fold at all three dose levels. The Estimated Concentration (EC) is 10-11%. Therefore, the test substance is a weak to moderate skin sensitizer.
- Executive summary:
The test substance, Formaldehyde, polymer with 1,3 -benzenedimethanamine and phenol was evaluated dermal sensitizing potential in an O.E.C.D. test guideline 429 mouse LLNA study. The test substance is a skin sensitizer under the conditions of the study inducing a SI of > 3-fold at all three dose levels. The Estimated Concentration (EC) is 10-11%. Therefore, the test substance is a weak to moderate skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
